Chii-min S. Hwu
No. 201, Sec. 2, Shipai Road
Beitou, TPQ 11217, Taiwan
Beitou, TPQ 11217, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
An in-hospital referral program for hepatitis c virus elimination in patients with type 2 diabetes mellitus.
Journal: Journal of the Chinese Medical Association : JCMA
Published: July 21, 2026
Advances in body composition imaging for diagnosis and monitoring: From radiologic assessment to precision medicine.
Journal: Journal of the Chinese Medical Association : JCMA
Published: June 02, 2026
The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials.
Journal: Frontiers in immunology
Published: April 28, 2026
Comparative Risk of Psoriatic Arthritis in Type 2 Diabetes: An Emulated Target Trial of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists.
Journal: Drug design, development and therapy
Published: April 03, 2026
Empirical comparison of iodine excretion estimated from spot urine samples with measured 24-hour urinary iodine excretion in healthy adults.
Journal: Journal of the Chinese Medical Association : JCMA
Published: March 06, 2026
SGLT2 inhibitors and the risk of incident chronic kidney disease in type 2 diabetes: a nationwide emulated target trial in Taiwan.
Journal: Diabetes research and clinical practice
Published: March 02, 2026
Microvascular complications and risk of osteoporosis and fractures in type 2 diabetes: a nationwide Asian cohort study.
Journal: Journal of endocrinological investigation
Published: January 09, 2026
Waist circumference is an important determinant of relative muscle strength in patients with type 2 diabetes mellitus: Erratum.
Journal: Journal of the Chinese Medical Association : JCMA
Published: December 26, 2025
Metformin use and the risk of incident immune-mediated diseases in patients with type 2 diabetes: a population-based cohort study.
Journal: Frontiers in immunology
Published: December 16, 2025
SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study.
Journal: Journal of the Royal Society of Medicine
Published: November 03, 2025
Last Updated: 09/26/2026